MURA

Mural Oncology plc - Ordinary Shares (MURA)

About Mural Oncology plc - Ordinary Shares (MURA)

Mural Oncology Plc is a clinical-stage oncology company, which focuses on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. Its lead product candidate is the Nemvaleukin Alfa which is an interleukin-2 cytokine designed to capture and expand therapeutic benefits of high-dose recombinant human IL-2. The company was founded on May 31, 2017 and is headquartered in Dublin, Ireland.

Details

Daily high

$2.66

Daily low

$2.52

Price at open

$2.65

52 Week High

$4.74

52 Week Low

$0.95

Market cap

44.8M

Dividend yield

0.00%

Volume

437,848

Avg. volume

14.9M

P/E ratio

-.34

Mural Oncology plc - Ordinary Shares News